Acute Myelocytic Leukemia
Item
Patients with aml or raeb 2 high risk mds who are newly diagnosed according to the who 2008 classification and previously untreated.
boolean
C0023467 (UMLS CUI [1])
MDS
Item
Patients with aml (arising from an antecedent hematologic disease [ahd]) or mds who may have had one prior regimen with commercially available agents for the treatment of their prior hematologic disease. the patients may not have had a prior therapy for their aml.
boolean
C3463824 (UMLS CUI [1])
Therapy-related acute myeloid leukemia and myelodysplastic syndrome
Item
aml patients include de novo aml, aml evolving from mds or other ahd and aml after previous cytotoxic therapy or radiation (secondary aml)
boolean
C1292776 (UMLS CUI [1])
Leukemic Blast Count
Item
For a diagnosis of aml, a bone marrow blast count of 20% or more is required.
boolean
C2697913 (UMLS CUI [1])
Bone marrow blasts
Item
For a diagnosis of high-risk myelodysplastic syndrome raeb 2 the patient must have 10-19% bone marrow blasts
boolean
C1982687 (UMLS CUI [1])
Organ function
Item
Adequate organ function
boolean
C1254358 (UMLS CUI [1])
ECOG
Item
ecog performance status 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
Acute Promyelocytic Leukemia
Item
aml m3 acute promyelocytic leukemia (apl) or patients with a t(9:22) cytogenetic translocation.
boolean
C0023487 (UMLS CUI [1])
Central nervous system leukaemia
Item
patients with known active uncontrolled central nervous system (cns) leukemia.
boolean
C1332884 (UMLS CUI [1])